FUNCTIONAL CURE BASED ON PEGYLATED INTERFERON α-2b THERAPY IN NUCLEOSIDE ANALOG-SUPPRESSED HBEAG NEGATIVE CHRONIC HEPATITIS B: A MULTICENTER REAL-WORLD STUDY (EVEREST PROJECT IN CHINA)-4 YEARS DATA UPDATE

被引：0

作者：

Mo, Zhishuo ^{[1
]}

Xie, Dongying ^{[1
]}

Fu, Lei ^{[2
]}

Zhang, Wenhua ^{[3
]}

Wei, Jia ^{[4
]}

Li, Guojun ^{[5
]}

Yang, Jiahong ^{[6
]}

Chen, Xinyue ^{[7
]}

Li, Jiabin ^{[8
]}

Shang, Jia ^{[9
]}

Guan, Yujuan ^{[10
]}

Jiang, Yongfang ^{[11
]}

Guo, Ying ^{[12
]}

Zeng, Yilan ^{[13
]}

Chang, Jiabao ^{[14
]}

Peng, Yanzhong ^{[15
]}

Lin, Minghua ^{[16
]}

Huang, Guangyu ^{[17
]}

Li, Jia ^{[18
]}

Gu, Shengwang ^{[19
]}

Geng, Jiawei ^{[20
]}

Gao, Zhiliang ^{[1
]}

机构：

[1] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou, Peoples R China

[2] Cent South Univ, Xiangya Hosp, Changsha, Peoples R China

[3] Gansu Wuwei Canc Hosp, Wuwei, Peoples R China

[4] Yunnan Univ, Affiliated Hosp, Kunming, Yunnan, Peoples R China

[5] Third Peoples Hosp Shenzhen, Shenzhen, Peoples R China

[6] Peoples Hosp Deyang City, Deyang, Peoples R China

[7] Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China

[8] Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China

[9] Henan Prov Peoples Hosp, Zhengzhou, Peoples R China

[10] Guangzhou Eighth Peoples Hosp, Guangzhou, Peoples R China

[11] Cent South Univ, Xiangya Hosp 2, Changsha, Peoples R China

[12] Third Peoples Hosp Taiyuan, Taiyuan, Peoples R China

[13] Chengdu Publ Hlth Med Ctr, Chengdu, Peoples R China

[14] Second Hosp Nanjing, Nanjing, Peoples R China

[15] Peking Univ, Shenzhen Hosp, Shenzhen, Peoples R China

[16] Fujian Med Univ, Mengchao Hepatobiliary Hosp, Fuzhou, Peoples R China

[17] Zhejiang Univ, Sch Med, Affiliated Hosp 4, Yiwu, Peoples R China

[18] Tianjin Second Peoples Hosp, Tianjin, Peoples R China

[19] Huaian Med Dist Gen Hosp Eastern Theater Command, Huaian, Peoples R China

[20] First Peoples Hosp Yunnan Prov, Kunming, Yunnan, Peoples R China

来源：

HEPATOLOGY | 2022年 / 76卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：S24 / S25

页数：2

共 13 条

[1] Functional cure based on pegylated interferon alpha therapy in nucleoside analog-suppressed HBeAg negative chronic hepatitis B: a multicenter real-world study (Everest Project in China)-3.5 years data update
Xie, Chan
Xie, Dongying
Fu, Lei
Zhang, Wen-hua
Wei, Jia
Li, Guojun
Yang, Jiahong
Chen, Xinyue
Li, Jia-bin
Shang, Jia
Guan, Yu-juan
Jiang, Yongfang
Guo, Ying
Zeng, Yi-lan
Chang, Jiabao
Peng, Yanzhong
Lin, Minghua
Huang, Guangyu
Li, Jia
Gu, Shengwang
Geng, Jia-wei
Gao, Zhiliang
JOURNAL OF HEPATOLOGY, 2022, 77 : S838 - S838
[2] Functional cure based on pegylated interferon ? in long-term nucleoside analog suppressed HBeAg negative chronic hepatitis B: a multicenter real-world study (Everest project in China), an interim report
Wu, Ze-Qian
Xie, Dong-Ying
Fu, Lei
Wei, Jia
Shang, Jia
He, Qing
Zhang, Wen-Hua
Huang, Guang-Yu
Peng, Yanzhong
Gu, Ye
Li, Jia-Bin
Guo, Ying
Guan, Yu-Juan
Geng, Jia-Wei
Zheng, Huan-Wei
Gao, Wen-Jun
Zhao, Wen-Jing
Tian, Ying-Jun
Zeng, Yi-Lan
Chen, Ren
Gu, Shengwang
Gao, Zhi-Liang
JOURNAL OF HEPATOLOGY, 2020, 73 : S886 - S887
[3] FUNCTIONAL CURE BASED ON PEGYLATED INTERFERON α IN LONG-TERM NUCLEOSIDE ANALOG SUPPRESSED HBEAG NEGATIVE CHRONIC HEPATITIS B: A MULTICENTER REAL-WORLD STUDY (EVEREST PROJECT IN CHINA), A SEQUENTIAL REPORT - THE PREDICTORS FOR HBsAg LOSS
Wu, Zeqian
Xie, Dongying
Fu, Lei
Zhang, Wenhua
Wei, Jia
Shang, Jia
Li, Guojun
Guo, Ying
Yang, Jiahong
Guan, Yujuan
Li, Jiabin
Chang, Jiabao
Huang, Guangyu
Peng, Yanzhong
Lin, Minghua
Zeng, Yilan
Li, Jia
Jiang, Jiaji
Jiang, Yongfang
Gu, Ye
Geng, Jiawei
Gao, Zhiliang
HEPATOLOGY, 2021, 74 : 483A - 483A
[4] Functional cure based on pegylated interferon α in long-term nucleoside analog suppressed HBeAg negative chronic hepatitis B: A multicenter real-world study (everest project in china), a sequential report the predictors for HBsAg loss
Wu, Ze-Qian
Xie, Dong-Ying
Fu, Lei
Zhang, Wenhua
Wei, Jia
Shang, Jia
Li, Guojun
Guo, Ying
Yang, Jiahong
Guan, Yujuan
Li, Jiabin
Chang, Jiabao
Huang, Guangyu
Peng, Yanzhong
Lin, MInghua
Zeng Yilan
Li, Jia
Jiang, Jiaji
Jiang, Yongfang
Gu, Ye
Geng, Jiawei
Gao, Zhi-liang
JOURNAL OF HEPATOLOGY, 2021, 75 : S759 - S759
[5] Functional cure and prediction analysis of pegylated interferon alpha-2b in HBeAg negative chronic hepatitis B patients with normal ALT (Ice-breaking Project in China): an interim analysis update
Zhang, Chong
Zeng, Dawu
Cai, Dachuan
Xue, Xiulan
Zhang, Lingyi
Song, Baojun
Gao, Yufeng
Huang, Yan
Shang, Jia
Wu, Xiaofeng
Zhang, Ying
Jin, Hua
Chen, Hui
Tang, Hong
Lu, Xiaobo
Guan, Yujuan
Min, Feng
Xu, Liang
Li, Gang
Wang, Zhenguang
Dou, Xiaoguang
JOURNAL OF HEPATOLOGY, 2024, 80 : S803 - S803
[6] Effect of pegylated interferon-α2b add-on therapy on renal function in chronic hepatitis B patients: A real-world experience
Peng, Mei-Juan
Guo, Xiao-Qing
Zhang, Wei-Lu
Chen, Jing
Kang, Wen
Yang, Xiao-Fei
Guo, Ying
Zhang, Ye
FRONTIERS IN MICROBIOLOGY, 2022, 13
[7] Efficacy and prediction analysis of pegylated interferon alpha-2b in treatment-naive HBeAg negative chronic hepatitis B patients with normal ALT: a multicenter real-world study (Ice-breakting Project in China)-Interim analysis
Zhang, Chong
Zeng, Da-Wu
Cai, Da-Chuan
Xue, Xiu-Lan
Zhang, Ling-Yi
Song, Bao-Jun
Gao, Yu-Feng
Huang, Yan
Shang, Jia
Wu, Xiao-Feng
Zhang, Ying
Jin, Hua
Chen, Hui
Tang, Hong
Lu, Xiaobo
Guan, Yujuan
Min, Feng
Xu, Liang
Li, Gang
Wang, Zhen-Guang
Dou, Xiaoguang
JOURNAL OF HEPATOLOGY, 2023, 78 : S1165 - S1166
[8] The Optimizing Treatment of Peg Interferon Alfa in Hbeag Negative Chronic Hepatitis B Patients with Low Level HBsAg: A Multicenter Real World Study (Interferon Cure Study, I CURE Study)
Gao, Zhiliang
Zhu, Xiang
Lin, Bingliang
Yi, Jianhua
Gao, Wenjun
Chen, Youming
Xie, Dongying
Deng, Hong
Lin, Chaoshuang
You, Jing
Zhang, Chunlan
Xie, Qifeng
Ye, Yinong
Zhang, Xiaohong
Peng, Liang
Gan, Weiqiang
Zhao, Qiyi
HEPATOLOGY, 2018, 68 : 246A - 246A
[9] 32.2% OF INACTIVE HBSAG CARRIERS ACHIEVED CLINICAL CURE AT 48 WEEKS WITH PEGYLATED INTERFERON ALPHA-2B THERAPY: A MULTICENTER REAL- WORLD STUDY ( STARHB PROJECT IN CHINA)-2-YEAR DATA UPDATE
Zhao, Jing
Ren, Shan
Zheng, Sujun
Lin, Bingliang
Jiang, Yongfang
Ruan, Qingfa
Huang, Yan
Zeng, Yilan
Geng, Jiawei
Cao, Haifang
Zhang, Wenhua
Guo, Ying
Mao, Xiaorong
Gao, Zhiliang
Shi, Tianyuan
Zhu, Yueyong
Yu, Zujiang
Wu, Xiaoping
Mao, Qing
Xue, Xiulan
He, Yingli
Shang, Jia
Dang, Shuangsuo
Zhao, Haidong
Fan, Rongshan
Yang, Jiangling
Lian, Jianqi
Gao, Haibing
Chen, Xinyue
HEPATOLOGY, 2024, 80 : S287 - S288
[10] Comparison of the Safety Profiles of Pegylated Interferon α-2a and α-2b Administered in Combination with Ribavirin for Chronic Hepatitis C Infection: A Real-World Retrospective Cohort Study
Ide, Kazuki
Sato, Izumi
Imai, Takumi
Hawke, Philip
Yamada, Hiroshi
Kawasaki, Yohei
Masaki, Naohiko
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2016, 39 (12) : 2060 - 2065

← 1 2 →